MERLO, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 16.638
EU - Europa 9.731
AS - Asia 4.525
SA - Sud America 86
AF - Africa 71
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 21
Totale 31.100
Nazione #
US - Stati Uniti d'America 16.566
IT - Italia 3.472
PL - Polonia 1.662
SG - Singapore 1.611
SE - Svezia 1.423
CN - Cina 1.420
HK - Hong Kong 901
DE - Germania 719
UA - Ucraina 485
BG - Bulgaria 364
FI - Finlandia 321
IE - Irlanda 291
TR - Turchia 208
GB - Regno Unito 206
CH - Svizzera 149
RU - Federazione Russa 126
FR - Francia 123
IN - India 99
NL - Olanda 78
VN - Vietnam 71
KR - Corea 65
BE - Belgio 62
CA - Canada 59
AT - Austria 56
JP - Giappone 46
ES - Italia 44
RO - Romania 42
BR - Brasile 36
CZ - Repubblica Ceca 29
EU - Europa 25
IR - Iran 23
SN - Senegal 23
GR - Grecia 20
CL - Cile 19
EG - Egitto 19
AU - Australia 18
CO - Colombia 13
PH - Filippine 11
MX - Messico 10
HR - Croazia 8
LT - Lituania 8
AR - Argentina 7
ID - Indonesia 7
MY - Malesia 7
TH - Thailandia 7
DK - Danimarca 6
IL - Israele 5
PE - Perù 5
SA - Arabia Saudita 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
TG - Togo 5
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
MA - Marocco 4
NO - Norvegia 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
CY - Cipro 3
EE - Estonia 3
HU - Ungheria 3
KW - Kuwait 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
PY - Paraguay 3
RS - Serbia 3
SC - Seychelles 3
TW - Taiwan 3
AL - Albania 2
AO - Angola 2
EC - Ecuador 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
SM - San Marino 2
TZ - Tanzania 2
UG - Uganda 2
ZA - Sudafrica 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
KE - Kenya 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
MW - Malawi 1
PA - Panama 1
Totale 31.098
Città #
Fairfield 2.068
Chandler 1.782
Warsaw 1.650
Woodbridge 1.499
Singapore 1.351
Ashburn 1.328
Ann Arbor 1.108
Houston 1.046
Seattle 879
Hong Kong 877
Wilmington 851
Cambridge 718
Trieste 648
Boardman 610
Jacksonville 540
Princeton 456
Sofia 363
Beijing 353
Columbus 328
Dublin 281
Milan 231
Santa Clara 213
Izmir 186
Rome 170
Dearborn 162
Helsinki 146
San Diego 118
Bern 113
Grafing 103
Naples 69
Bremen 67
Dong Ket 66
Washington 58
Brussels 56
Seoul 54
Redwood City 53
Venezia 52
Guangzhou 50
London 48
Des Moines 47
Falls Church 46
Jinan 46
Munich 46
Udine 46
Venice 45
Vienna 44
Shanghai 43
Lappeenranta 42
Pune 42
Los Angeles 41
Chicago 40
Nanjing 40
Turin 38
Mestre 36
Amsterdam 35
Norwalk 35
Redmond 33
Dallas 32
Florence 31
Padova 30
Kunming 28
Hefei 27
Bologna 26
Palermo 26
Toronto 26
Dakar 23
São Paulo 23
Tokyo 22
Bari 21
Paris 21
Treviso 21
Catania 19
Parma 19
Phoenix 19
Frankfurt am Main 17
Fremont 17
Mumbai 17
Napoli 17
Verona 17
Brescia 16
Perugia 16
Buffalo 15
Karlsruhe 15
Olomouc 15
San Francisco 15
Timisoara 15
Wuhan 15
Zhengzhou 15
Cagliari 14
Council Bluffs 14
Nanchang 14
Shenyang 14
Boydton 13
Changsha 13
New York 13
Pisa 13
Chengdu 12
Dongguan 12
Leawood 12
San Mateo 12
Totale 22.288
Nome #
Miocardite, cardiomiopatia infiammatoria e perimiocardite: possiamo fare ordine? 353
Natural History of Dilated Cardiomyopathy in Children 353
Role of Titin Missense Variants in Dilated Cardiomyopathy 343
Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life-Threatening Arrhythmias 340
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 308
Persistent recovery of normal left ventricular function and dimension in idiopathic dilated cardiomyopathy during long‐term follow‐up: does real healing exist? 304
Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives 291
Conflicting gender-related differences in the natural history of patients with idiopathic dilated cardiomyopathy 270
null 266
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 255
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 254
Arresto cardiaco extraospedaliero: le competenze degli studenti dell’Università degli Studi di Trieste sulle manovre rianimatorie e l’utilizzo del defibrillatore automatico esterno 254
I dieci punti che il cardiologo deve conoscere su scintigrafia miocardica con traccianti ossei, amiloidosi e cuore 238
Impact of Aging on Heart Rate Variability Properties of Healthy Subjects 229
Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: data from the Trieste Cardiomyopathies Registry. 229
Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy 226
Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History 223
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 215
Com'è cambiata la storia naturale della cardiomiopatia dilatativa? 214
La cardiomiopatia dilatativa come malattia dinamica: storia naturale, rimodellamento inverso e stratificazione prognostica 209
Treatment of Functional Mitral Regurgitation in Heart Failure 206
Prognostic impact of short-term changes of E/E' ratio and left atrial size in dilated cardiomyopathy 204
Historical Terminology, Classifications, and Present Definition of DCM. 204
Dieci quesiti in tema di miocardite eosinofila [Ten questions about eosinophilic myocarditis] 198
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 194
Documento di consenso Società Italiana di Cardiologia- Società Italiana di Nefrologia: Ruolo dell’asse cardio-renale nella prevenzione e trattamento delle patologie cardiovascolari – Parte II: Dalle strategie di prevenzione al trattamento del paziente con coinvolgimento cardio-renale 191
Interchangeability of B type natriuretic peptide measurements in lithium heparin and K2EDTA: agreement between matrices and differences in diagnostic accuracy. 191
Influence of Aging on Short- and Long-term Heart Rate Variability in Patients with Heart Failure 189
Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. 188
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 186
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy 185
Chapter 6: Clinical Presentation, Spectrum of Disease, and Natural History 184
Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? 183
HRV analysis in CHF patients with different etiologies by means of spectral and nonlinear indexes 183
Predictors for Restoration of Normal Left Ventricular Function in Response to Cardiac Resynchronization Therapy Measured at Time of Implantation. 182
Emergency Surgery and Cardiac Devices 181
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 181
Predicting device failure after percutaneous repair of functional mitral regurgitation in advanced heart failure: Implications for patient selection 179
Evolving concepts in dilated cardiomyopathy 178
Arrhythmic Risk Stratification in Patients With Idiopathic Dilated Cardiomyopathy 177
Genetics of Dilated Cardiomyopathy: Clinical Implications 176
DEFINITION, CLASSIFICATION, EPIDEMIOLOGY, AND CLINICAL RELEVANCE OF CARDIOMYOPATHIES. 175
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 170
Acute Hemodynamic Response to Cardiac Resynchronization in Dilated Cardiomyopathy: Effect on Late Mitral Regurgitation 169
Formation of the inflammasome in acute myocarditis. 167
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 167
Chapter 12: Prognostic Stratification and Importance of Follow-Up 167
The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance. 166
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseases 166
Myocarditis evolving in cardiomyopathy: When genetics and offending causes work together 166
Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. 165
Echocardiographic evaluation of systolic and mean pulmonary artery pressure in the follow-up of patients with pulmonary hypertension. 164
Dilated Cardiomyopathy. From Genetics to Clinical Management 164
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 164
Apoptosis in patients with acute myocarditis. 163
Myocarditis in Clinical Practice 163
Hypertrophic cardiomyopathy: Clinical assessment and differential diagnosis 163
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 163
Cardiac amyloidosis: a changing epidemiology with open challenges 162
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 162
Prognostic role of hemodynamic evaluation at rest and at maximum workload in patients with idiopathic dilated cardiomyopathy. 159
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 158
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy 158
Cardiovascular aging: the unveiled enigma from bench to bedside 157
Prognostic Impact of BNP Variations in Patients Admitted for Acute Decompensated Heart Failure with In-Hospital Worsening Renal Function 157
Long-Term Evolution and Prognostic Stratification of Biopsy-Proven Active Myocarditis 156
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 156
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 154
ST-elevation myocardial infarction with reduced left ventricular ejection fraction: Insights into persisting left ventricular dysfunction. A pPCI-registry analysis 154
null 153
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 152
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 152
Early right ventricular response to cardiac resynchronization therapy: Impact on clinical outcomes 149
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 148
Contemporary etiology and prognosis of dilated non-ischemic cardiomyopathy 148
Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment. 147
Chapter 14: Unresolved Issues and Future Perspectives 145
Chapter 3: Pathophysiology 145
Idiopathic dilated cardiomyopathy and persistent viral infection: Lack of association in a controlled study using a quantitative assay. 143
Prognostic value of cardiopulmonary exercise testing in Idiopathic Dilated Cardiomyopathy 143
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 142
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 140
Clinical management of dilated cardiomyopathy: Current knowledge and future perspectives 134
The (ultra) sound of a burning heart: A matter of speckles 133
Insights into mildly dilated cardiomyopathy: Temporal evolution and long-term prognosis 132
Truncations of titin causing dilated cardiomyopathy 131
Pulmonary artery aneurysm and sarcoidosis 131
null 131
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment 131
Usefulness of Addition of Magnetic Resonance Imaging to Echocardiographic Imaging to Predict Left Ventricular Reverse Remodeling in Patients With Nonischemic Cardiomyopathyhttps://arts.units.it/submit?resume=115962# 130
Left ventricular reverse remodeling prediction in non-ischemic cardiomyopathy: present and perspectives 130
null 128
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm 127
Prognostic impact of familial screening in dilated cardiomyopathy. 126
Characterization and Long-Term Prognosis of Postmyocarditic Dilated Cardiomyopathy Compared With Idiopathic Dilated Cardiomyopathy 126
Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias 126
Gender medicine in dilated cardiomyopathy: pride and prejudice 125
Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. 124
Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy. 123
Heart failure and personalized medicine 121
Totale 18.085
Categoria #
all - tutte 107.839
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.839


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.198 0 0 0 0 0 543 552 494 617 368 350 274
2020/20214.697 332 378 388 749 522 474 346 328 209 423 183 365
2021/20223.225 127 224 219 250 180 306 153 92 376 335 230 733
2022/20235.515 421 701 543 839 459 867 82 464 585 120 276 158
2023/20244.918 360 263 224 363 432 521 765 712 124 188 530 436
2024/20254.075 326 630 1.066 955 975 123 0 0 0 0 0 0
Totale 32.511